Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Health Catalyst, Inc. HCAT

Healthcare  —  Health Information Services
1.74 0.00 0.00% as of 25 Sep
Market cap
$131.0M
P/E
0.0×
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio 0.00 0.00 4.20 9.11 7.78 2.02 1.74 1.39 0.54
P/FCF ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF (23.15) (23.15) (49.79) (415.65) (192.51) (37.66) (27.02) (120.64) 16.85
P/B ratio 0.00 0.00 3.24 6.23 3.60 1.31 1.40 1.17 0.68
Price to Tangible BV 0.00 0.00 3.79 24.82 7.61 3.80 5.00 21.94 0.00
EV/Sales 0.00 0.00 3.05 8.59 6.70 1.54 1.45 1.36 0.72
EV/EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 62.48
EV/Operating CF (3.50) (3.50) (14.70) (62.03) (70.11) (12.04) (12.95) 28.56 307.21
EV/FCF (3.30) (3.30) (12.98) (44.32) (39.00) (1.18) (9.04) (227.75) (10.81)
Quick Ratio 2.23 1.46 5.31 3.63 5.31 4.99 4.25 1.38 1.73
Current Ratio 2.30 1.60 5.48 3.75 5.46 5.18 4.42 1.43 1.89
Net Debt/EBITDA 0.98 0.25 3.98 1.43 2.77 1.48 1.08 0.38 16.00
Debt/Assets 0.00% 18.11% 16.87% 29.70% 22.16% 30.57% 32.49% 44.52% 30.49%
Debt/Equity 0.00 (0.05) 0.25 0.62 0.35 0.54 0.62 1.05 0.62
Asset Turnover 0.66 2.03 0.75 0.43 0.34 0.35 0.41 0.39 0.46
Operating CF/Net income 0.63 0.35 0.13 0.23 0.15 0.26 0.28 (0.21) 0.00
Capex/Depreciation (0.55) (0.31) (0.41) (0.39) (0.37) (6.51) (0.33) (0.37) (0.13)
Interest Coverage 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE 18.54% 35.95% 276.72% (48.25%) (38.39%) (29.02%) (29.84%) (18.99%) (58.26%)
ROA (53.14%) (205.49%) (116.57%) (26.14%) (21.73%) (17.34%) (16.25%) (8.91%) (26.14%)
ROIC 0.00% 0.00% (146.71%) (33.97%) (34.34%) (30.02%) (28.61%) (12.27%) (33.15%)
Return on Tangible Assets (129.94%) (383.55%) (109.35%) (45.17%) (34.93%) (37.01%) (35.79%) (41.08%) (156.71%)
Average Days of Receivables 85.17 89.80 64.95 93.35 73.63 63.38 74.36 68.08 69.36
Research and Development Expense of Revenue 38.96% 34.28% 29.85% 28.34% 25.93% 27.40% 24.54% 18.90% 16.00%
Selling, General and Administrative Expense of Revenue 55.58% 59.35% 50.99% 60.71% 66.53% 54.02% 48.62% 36.27% 32.79%
Intangible Assets out of Total Assets 0.00 0.29 0.10 0.36 0.33 0.37 0.38 0.40 0.57
Share Based Compensation of Revenue 5.80% 3.73% 11.52% 20.10% 26.93% 26.10% 18.84% 13.09% 8.68%
Graham Net Nets 0.34 0.34 0.25 0.02 0.11 0.18 0.11 (0.07) (0.52)
Graham Number 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield (7.71%) (7.71%) (22.11%) (6.59%) (8.10%) (24.45%) (23.03%) (16.27%) (106.28%)
Free Cash Flow Yield (29.36%) (29.36%) (5.61%) (2.13%) (2.21%) (64.38%) (9.20%) (0.43%) (12.44%)
Revenue per Share 15.08 23.46 8.27 4.78 5.09 5.14 5.25 5.09 4.45
Operating CF per Share (7.60) (8.40) (1.72) (0.66) (0.49) (0.66) (0.59) 0.24 0.01
Capex per Share (0.68) (0.52) (0.23) (0.26) (0.39) (6.03) (0.25) (0.27) (0.31)
Free Cash Flow per Share (8.28) (8.91) (1.95) (0.93) (0.88) (6.69) (0.84) (0.03) (0.30)
Cash per Share 10.62 6.92 12.18 6.85 9.37 6.77 5.63 6.51 1.37
Shareholders Equity per Share 0.00 (78.11) 10.71 6.98 10.99 7.91 6.50 6.07 3.52
Interest Debt per Share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share 0.00 (78.11) 10.71 6.98 10.99 7.91 6.50 6.07 3.52
Free Cash Flow (40.13) (42.77) (36.46) (36.60) (41.57) (359.36) (47.36) (1.83) (20.78)
Working Capital 39.86 25.05 216.02 241.76 415.34 345.29 304.36 139.80 79.73
Capital Expenditures (3.30) (2.47) (4.27) (10.45) (18.44) (324.09) (14.28) (16.38) (21.51)
Net Current Asset Value 70.62 (418.88) 162.52 28.16 198.39 100.52 58.50 (28.07) (87.56)
EV/EBIT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales 0.05 0.02 0.03 0.06 0.08 1.17 0.05 0.05 0.07
Net Profit Margin (80.43%) (101.29%) (155.49%) (60.91%) (63.33%) (49.74%) (39.92%) (22.67%) (57.20%)
Price to Operating Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets 1.12 1.70 2.40 2.08 2.12 1.92 1.70 1.52 4.86
Cash ROIC (65.86%) 13.99% (7.60%) (5.43%) (4.03%) (6.01%) (6.44%) (1.30%) (6.69%)
Accounts Receivable Turnover 3.27 5.03 5.61 4.98 4.98 5.71 5.47 5.22 5.35
Accounts Payable Turnover 33.00 45.26 27.73 21.91 24.81 31.38 29.66 18.35 15.34
Inventory Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables 6.97 11.05 17.55 19.84 13.77 11.29 14.77 25.17 21.43
Days of Inventory on Hand 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables 22.37 22.37 27.63 37.93 48.55 48.39 54.13 58.74 58.16
Average Payables 1.32 1.32 2.72 4.48 5.01 4.56 5.53 9.04 10.40
Average Assets 110.62 55.49 206.67 440.05 704.92 792.19 727.05 780.37 680.79
Average Common Equity (317.12) (317.12) (87.06) 238.37 399.10 473.55 395.96 366.06 305.49

Fold the line items

Columns are period end dates